Vorinostat Completed Phase 1 Trials for Cancer, Advanced Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01339871Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
NCT00106626Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
NCT00750178A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)